Janux Therapeutics (JANX) IPO Doubles on Open

Today's IPO for Janux Therapeutics (NASDAQ: JANX) opened for trading at $34 after pricing 11,400,000 shares of its common stock at $17.

BofA Securities, Cowen and Evercore ISI are acting as joint book-running managers for the offering. H.C. Wainwright & Co. is acting as lead manager for the offering.

Janux Therapeutics is a biopharmaceutical company developing novel T cell engager immunotherapies.

You May Also Be Interested In

• Nscale Touts $51 Billion In Contracts, Targets September US IPO - Bloomberg
• Tenable Mentioned as short at Bear Cave
• Attovia Therapeutics raises $332.4M in Nasdaq IPO